gozetotide · Medicine question

In which patient population is Locametz (gozetotide) indicated for PET imaging after radiolabelling with gallium-68?

Name: In which patient population is Locametz (gozetotide) indicated for PET imaging after radiolabelling with gallium-68?
Published: 2026-11-08T14:18:57.080Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Locametz (gozetotide), after radiolabelling with gallium-68, is indicated for diagnostic PET identification of prostate-specific membrane antigen (PSMA)-positive lesions in adult patients with prostate cancer.

Sources for this answer

Locametz 25 micrograms kit for radiopharmaceutical preparationNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated 2 May 2024

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about gozetotide